The MDR1 C3435T polymorphism: Effects on P-glycoprotein expression/function and clinical significance

Por Dresser, Mark J.
Publicado em 2001

A clinical drug–drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor...

Por Malhi, Vikram, Colburn, Dawn, Williams, Sarah J., Hop, Cornelis E. C. A., Dresser, Mark J., Chandra, Priya, Graham, Richard A.
Publicado no Cancer Chemother Pharmacol (2016)

Gastric Re-acidification with Betaine HCl in Healthy Volunteers with Rabeprazole-Induced Hypochlorhydria

Por Yago, Marc Anthony R., Frymoyer, Adam R., Smelick, Gillian S., Frassetto, Lynda A., Budha, Nageshwar R., Dresser, Mark J., Ware, Joseph A., Benet, Leslie Z.
Publicado em 2013

Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects

Por Graham, Richard A, Hop, Cornelis E C A, Borin, Marie T, Lum, Bert L, Colburn, Dawn, Chang, Ilsung, Shin, Young G, Malhi, Vikram, Low, Jennifer A, Dresser, Mark J
Publicado em 2012

The Use of Betaine HCl to Enhance Dasatinib Absorption in Healthy Volunteers with Rabeprazole-Induced Hypochlorhydria

Por Yago, Marc R., Frymoyer, Adam, Benet, Leslie Z., Smelick, Gillian S., Frassetto, Lynda A., Ding, Xiao, Dean, Brian, Salphati, Laurent, Budha, Nageshwar, Jin, Jin Y., Dresser, Mark J., Ware, Joseph A.
Publicado no AAPS J (2014)